Alphagan P (Brimonidine Tartrate Ophthalmic) - Indications and Dosage

INDICATIONS AND USAGE

ALPHAGAN^® P is indicated for the lowering of intraocular pressure in patients with open-angle glaucoma or ocular hypertension.

DOSAGE AND ADMINISTRATION

The recommended dose is one drop of ALPHAGAN^® P in the affected eye(s) three times daily, approximately 8 hours apart.

ALPHAGAN^® P ophthalmic solution may be used concomitantly with other topical ophthalmic drug products to lower intraocular pressure. If more than one topical ophthalmic product is being used, the products should be administered at least 5 minutes apart.

HOW SUPPLIED:

ALPHAGAN^® P is supplied sterile in opaque teal LDPE plastic bottles and droppers with purple high impact polystyrene (HIPS) caps as follows:

0.1%

        5 mL in 10 mL bottle         NDC 0023-9321-05
      10 mL in 10 mL bottle         NDC 0023-9321-10
      15 mL in 15 mL bottle         NDC 0023-9321-15

0.15%

        5 mL in 10 mL bottle         NDC 0023-9177-05
      10 mL in 10 mL bottle         NDC 0023-9177-10
      15 mL in 15 mL bottle         NDC 0023-9177-15

NOTE: Store at 15°-25° C (59-77°F).

Rx Only

© 2005 Allergan, Inc.
Irvine, CA 92612, U.S.A.

® Marks owned by Allergan
US Pat. 5,424,078; 5,736,165; 6,194, 415; 6,248,741; 6,465,464; 6,562,873; 6,627,210; 6,641,834; 6,673,337

0.1%- 9541X
0.15%- 9174X
71816US10S